Fundz

OnCusp Therapeutics Appoints Dimitry S.A. Nuyten as Chief Medical Officer

PRIVATEJun 23, 2025

Position

Chief Medical Officer

Company

OnCusp Therapeutics

Dimitry S.A. Nuyten
dimitry.nuyten@oncusptx.com
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

OnCusp Therapeutics, Inc. has announced the appointment of Dimitry S.A. Nuyten, M.D., Ph.D., as their new Chief Medical Officer

Company Information

Company

OnCusp Therapeutics

Location

New York, New York, United States

About

OnCusp Therapeutics is transforming a growing portfolio of cutting-edge molecules into innovative treatments that deliver help and hope to cancer patients worldwide. The company is led by a founding team that has deep experience in business development, clinical development and building start-up biopharmaceutical company. OnCusp continually strives to optimize the largest value inflection point in the drug development value chain and believes that accelerating oncology drug innovation is the best way to deliver help and hope to cancer patients worldwide.

Fundz sees it the moment OnCusp Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Bing
Likely contact at this company
••••••••@••••••••

See Bing's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for OnCusp Therapeutics's next move

Learn about Strategic plan

OnCusp Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.